Biogen Idec (BIIB) option volume lightens as volatility stays low a day after buyout chatter
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) is recently down $1.13 to $50.28. Credit Suisse has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
